Ari Moskowitz1, Lars W Andersen2,3,4, Michael N Cocchi2,5, Mathias Karlsson2,3, Parth V Patel2, Michael W Donnino1,2. 1. 1 Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine. 2. 2 Department of Emergency Medicine, and. 3. 3 Research Center for Emergency Medicine, and. 4. 4 Department of Anesthesiology, Aarhus University Hospital, Aarhus, Denmark. 5. 5 Division of Critical Care, Department of Anesthesia and Critical Care, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
Abstract
RATIONALE: Acute kidney injury (AKI) is common in patients with sepsis and has been associated with high mortality rates. The provision of thiamine to patients with sepsis may reduce the incidence and severity of sepsis-related AKI and thereby prevent renal failure requiring renal replacement therapy (RRT). OBJECTIVES: To test the hypothesis that thiamine supplementation mitigates kidney injury in septic shock. METHODS: This was a secondary analysis of a single-center, randomized, double-blind trial comparing thiamine to placebo in patients with septic shock. Renal function, need for RRT, timing of hemodialysis catheter placement, and timing of RRT initiation were abstracted. The baseline creatinine and worst creatinine values between 3 and 24 hours, 24 and 48 hours, and 48 and 72 hours were likewise abstracted. RESULTS: There were 70 patients eligible for analysis after excluding 10 patients in whom hemodialysis was initiated before study drug administration. Baseline serum creatinine in the thiamine group was 1.2 mg/dl (interquartile range, 0.8-2.5) as compared with 1.8 mg/dl (interquartile range, 1.3-2.7) in the placebo group (P = 0.3). After initiation of the study drug, more patients in the placebo group than in the thiamine group were started on RRT (eight [21%] vs. one [3%]; P = 0.04). In the repeated measures analysis adjusting for the baseline creatinine level, the worst creatinine levels were higher in the placebo group than in the thiamine group (P = 0.05). CONCLUSIONS: In this post hoc analysis of a randomized controlled trial, patients with septic shock randomized to receive thiamine had lower serum creatinine levels and a lower rate of progression to RRT than patients randomized to placebo. These findings should be considered hypothesis generating and can be used as a foundation for further, prospective investigation in this area.
RCT Entities:
RATIONALE: Acute kidney injury (AKI) is common in patients with sepsis and has been associated with high mortality rates. The provision of thiamine to patients with sepsis may reduce the incidence and severity of sepsis-related AKI and thereby prevent renal failure requiring renal replacement therapy (RRT). OBJECTIVES: To test the hypothesis that thiamine supplementation mitigates kidney injury in septic shock. METHODS: This was a secondary analysis of a single-center, randomized, double-blind trial comparing thiamine to placebo in patients with septic shock. Renal function, need for RRT, timing of hemodialysis catheter placement, and timing of RRT initiation were abstracted. The baseline creatinine and worst creatinine values between 3 and 24 hours, 24 and 48 hours, and 48 and 72 hours were likewise abstracted. RESULTS: There were 70 patients eligible for analysis after excluding 10 patients in whom hemodialysis was initiated before study drug administration. Baseline serum creatinine in the thiamine group was 1.2 mg/dl (interquartile range, 0.8-2.5) as compared with 1.8 mg/dl (interquartile range, 1.3-2.7) in the placebo group (P = 0.3). After initiation of the study drug, more patients in the placebo group than in the thiamine group were started on RRT (eight [21%] vs. one [3%]; P = 0.04). In the repeated measures analysis adjusting for the baseline creatinine level, the worst creatinine levels were higher in the placebo group than in the thiamine group (P = 0.05). CONCLUSIONS: In this post hoc analysis of a randomized controlled trial, patients with septic shock randomized to receive thiamine had lower serum creatinine levels and a lower rate of progression to RRT than patients randomized to placebo. These findings should be considered hypothesis generating and can be used as a foundation for further, prospective investigation in this area.
Entities:
Keywords:
beriberi; mitochondria; multiple organ failure; renal insufficiency; sepsis
Authors: Hernando Gomez; Can Ince; Daniel De Backer; Peter Pickkers; Didier Payen; John Hotchkiss; John A Kellum Journal: Shock Date: 2014-01 Impact factor: 3.454
Authors: Carolina Rosa Gioda; Tatiane de Oliveira Barreto; Thales Nicolau Prímola-Gomes; Daniel Carvalho de Lima; Paula Peixoto Campos; Luciano dos Santos Aggunn Capettini; Sandra Lauton-Santos; Anilton César Vasconcelos; Cândido C Coimbra; Virginia Soares Lemos; Jorge L Pesquero; Jader S Cruz Journal: Am J Physiol Heart Circ Physiol Date: 2010-03-19 Impact factor: 4.733
Authors: Kianoush Kashani; Ali Al-Khafaji; Thomas Ardiles; Antonio Artigas; Sean M Bagshaw; Max Bell; Azra Bihorac; Robert Birkhahn; Cynthia M Cely; Lakhmir S Chawla; Danielle L Davison; Thorsten Feldkamp; Lui G Forni; Michelle Ng Gong; Kyle J Gunnerson; Michael Haase; James Hackett; Patrick M Honore; Eric A J Hoste; Olivier Joannes-Boyau; Michael Joannidis; Patrick Kim; Jay L Koyner; Daniel T Laskowitz; Matthew E Lissauer; Gernot Marx; Peter A McCullough; Scott Mullaney; Marlies Ostermann; Thomas Rimmelé; Nathan I Shapiro; Andrew D Shaw; Jing Shi; Amy M Sprague; Jean-Louis Vincent; Christophe Vinsonneau; Ludwig Wagner; Michael G Walker; R Gentry Wilkerson; Kai Zacharowski; John A Kellum Journal: Crit Care Date: 2013-02-06 Impact factor: 9.097
Authors: Scott L Weiss; Bridget Blowey; Luke Keele; Rebecca Ganetzky; Chaya N Murali; Julie C Fitzgerald; Robert M Sutton; Robert A Berg Journal: Pediatr Crit Care Med Date: 2019-09 Impact factor: 3.624
Authors: Pietro E Cippà; Sophie de Seigneux; David Legouis; Sven-Erick Ricksten; Anna Faivre; Thomas Verissimo; Karim Gariani; Charles Verney; Pierre Galichon; Lena Berchtold; Eric Feraille; Marylise Fernandez; Sandrine Placier; Kari Koppitch; Alexandre Hertig; Pierre-Yves Martin; Maarten Naesens; Jérôme Pugin; Andrew P McMahon Journal: Nat Metab Date: 2020-07-20
Authors: Ari Moskowitz; David T Huang; Peter C Hou; Jonathan Gong; Pratik B Doshi; Anne V Grossestreuer; Lars W Andersen; Long Ngo; Robert L Sherwin; Katherine M Berg; Maureen Chase; Michael N Cocchi; Jessica B McCannon; Mark Hershey; Ayelet Hilewitz; Maksim Korotun; Lance B Becker; Ronny M Otero; Junior Uduman; Ayan Sen; Michael W Donnino Journal: JAMA Date: 2020-08-18 Impact factor: 56.272